Mounjaro®
Starting from £179.99/mo
Start journey Learn moreFood noise is the persistent, intrusive mental chatter about food (cravings, thoughts about what to eat next, fixation on snacks) that many people find exhausting. Semaglutide (Wegovy) appears to reduce it significantly for a large proportion of users, though it works differently from person to person. These are prescription-only medicines; a clinician assesses whether they're suitable for you before anything is prescribed.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Most coverage collapses food noise into ordinary hunger. They're not the same thing. Hunger is a physical signal, an empty stomach, falling blood glucose, a growl. Food noise is cognitive: thoughts about food that arrive when you're not physically hungry, that interrupt a work call or a night's sleep, that make you reconsider a decision you already made. Plenty of people who experience severe food noise eat enough; the problem is the mental load, not the calorie gap.
Semaglutide does slow gastric emptying and reduces appetite through the gut, that part is well established. But the quieting of food noise appears to come from somewhere else. GLP-1 receptors are found in the hypothalamus and other reward-processing areas of the brain, and semaglutide crosses into the central nervous system. The leading hypothesis is that activating those receptors damps the dopamine-driven reward salience of food cues: the smell of a bakery, an advert, a colleague's lunch. The food is still there; it just stops commanding your attention the way it did. More about how Wegovy works as a treatment is on our overview page.
This distinction matters practically. Someone who expects only physical appetite suppression may be surprised when the first change they notice is being able to walk past the biscuit tin without a second thought. That's not placebo. It's a real neurological effect that researchers are still characterising, and it's the reason food noise reduction is increasingly discussed separately from weight loss in clinical literature, including data reviewed for NICE's recommendation of semaglutide (TA875).
In trial settings, questionnaire data from the STEP programme consistently showed improvements in eating behaviour scores alongside weight loss. In practice, the accounts our prescribers hear most often go like this: food stops feeling like a constant negotiation. People describe deciding not to finish a meal and simply not thinking about it again, where before they'd have replayed the choice for hours. Some describe it as the first period of genuine quiet around food they can remember.
This isn't universal. A proportion of people on semaglutide report little change in food noise while still losing weight through reduced appetite at mealtimes. Others find the quieting effect is strongest in the first months and softens slightly as they settle into maintenance doses. The NHS's patient information for semaglutide covers the medicine's broader effects on appetite and how the body responds.
A quick check worth doing once you've been on treatment for a few weeks: notice whether you're thinking about food less between meals, not just eating less at them. That distinction tells you whether the central effect is doing its job. It takes under a minute and gives you something concrete to report back to your prescriber at your next review.
If you want to understand whether Wegovy stops food noise completely or just reduces it, that question gets a longer answer of its own.
One of the more difficult experiences people report is food noise returning after a missed injection, during a dose reduction, or after stopping treatment altogether. This is biologically predictable. Without semaglutide maintaining receptor activation in those brain areas, the reward salience of food cues reverts. It doesn't mean the medicine stopped working; it means the medicine was working.
This is also why food noise coming back on Wegovy deserves clinical attention rather than self-managed dose changes. Titration decisions, pauses, and stopping plans are conversations for your prescriber, not adjustments to make unilaterally. The return of food noise after stopping treatment is part of the broader evidence that ongoing support matters as much as the prescription itself.
For anyone thinking about what to eat alongside treatment, practical guidance on eating well on Wegovy covers protein, fibre and hydration in a format your prescriber will recognise. And if you're weighing up how much all of this costs in real terms, the Wegovy cost page sets out what private treatment typically involves, including what a transparent price should actually cover.
Semaglutide is the only GLP-1 medicine in this class with a UK weight-management licence under the Wegovy brand, Ozempic is the same molecule but licensed strictly for type 2 diabetes, not weight loss. The food-noise effect described here applies specifically to semaglutide in its Wegovy formulation, used for the licensed indication. Other GLP-1 and dual-agonist medicines work through related but not identical pathways; comparisons are best handled at consultation.
The food noise and semaglutide page goes deeper into the receptor science for anyone who wants more detail. If the central question is how reliably Wegovy quiets food noise across different people and doses, that sits in its own section too. These are prescription-only medicines, and whether any of this is relevant to your situation is something our prescribers work through with you individually. Check your eligibility through a free consultation if you'd like that clinical view.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.